Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Prepaid Assets (2015 - 2026)

Mesoblast (MESO) posted Prepaid Assets of $7.5 million for Q4 2025, up 32.65% sequentially from $5.7 million in Q2 2025, and up 69.15% YoY from $4.5 million in Q4 2024.

Analysis

Mesoblast (MESO) Prepaid Assets (2015 - 2026) Analysis & Trends

Mesoblast has reported Prepaid Assets for 11 years, with the latest figure at $7.5 million in Q4 2025.

  • Quarterly Prepaid Assets rose 69.15% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (up 69.15% YoY) and the FY2025 annual result came in at $5.7 million, up 122.93% from the prior year.
  • Prepaid Assets grew to $7.5 million in Q4 2025 per MESO's latest filing, from $5.7 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $8.6 million in Q1 2021 and troughed at $2.6 million in Q2 2024.
  • A 5-year average of $5.2 million and a median of $5.0 million in 2022 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 33.28% in 2023, then jumped 122.93% in 2025.
  • Over 5 years, Prepaid Assets stood at $7.9 million in 2021, then plunged by 31.66% to $5.4 million in 2022, then plunged by 33.28% to $3.6 million in 2023, then advanced by 23.82% to $4.5 million in 2024, then soared by 69.15% to $7.5 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $7.5 million, $5.7 million, and $4.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.81 Mn
Dec 31, 2025 7.54 Mn
Jun 30, 2025 5.69 Mn
Dec 31, 2024 4.46 Mn
Jun 30, 2024 2.55 Mn
Dec 31, 2023 3.60 Mn
Jun 30, 2023 3.34 Mn
Mar 31, 2023 4.17 Mn
Dec 31, 2022 5.40 Mn
Sep 30, 2022 3.60 Mn
Jun 30, 2022 4.99 Mn
Mar 31, 2022 5.74 Mn
Dec 31, 2021 7.90 Mn
Sep 30, 2021 4.64 Mn
Jun 30, 2021 6.50 Mn
Mar 31, 2021 8.56 Mn
Dec 31, 2020 9.59 Mn
Sep 30, 2020 5.17 Mn
Jun 30, 2020 5.65 Mn
Mar 31, 2020 6.32 Mn